The Online Investor
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Thu., Aug. 6, 3:53 PM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #88. Elanco, the animal health division of Eli Lilly and Company Lohmann Animal Health

Acquirer: Elanco, the animal health division of Eli Lilly and Company (NYSE:LLY)
Acquiree: Lohmann Animal Health
Details: Elanco, the animal health division of Eli Lilly and Company (NYSE:LLY), today announced an agreement to acquire Lohmann SE (Lohmann Animal Health), a privately-held company headquartered in Cuxhaven, Germany. Lohmann Animal Health is a global leader in the supply of poultry vaccines and also markets a range of feed additives. The acquisition will establish Elanco as a global poultry leader, solidify Elanco's vaccine presence, broaden Elanco's product offerings and significantly augment Elanco's vaccine manufacturing capabilities.

Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s human pharmaceutical products include: diabetes and other endocrinology products, immunology products, neuroscience products, oncology products, and other products. Co.'s diabetes and other endocrinology products include: Baqsimi® and Basaglar®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta® and Emgality®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux® and Verzenio®. Co.'s other products include: Cialis®.

Eli Lilly SEC Filing Email Alerts Service


Open the LLY Page at The Online Investor »

Company Name: 
Lilly (Eli) & Co
Stock buyback: 
LLY buyback
Website: 
www.lilly.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding LLY: 
117
Total Market Value Held by ETFs: 
$14.34B
Total Market Capitalization: 
$143.75B
% of Market Cap. Held by ETFs: 
9.98%
 

Open the LLY Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Buy (3.40 out of 4)
59th percentile
(ranked higher than approx. 59% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 88 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.